Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Transfer factor and hepatitis B: a double blind study.

R Ellis-Pegler, D C Sutherland, R Douglas

Clinical and Experimental Immunology

|May 1, 1979

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A pilot randomized controlled trial of dexamphetamine in patients with chronic fatigue syndrome.

Psychosomatics·2003

Same author

Improving medical diagnoses by understanding how they are made.

Internal medicine journal·2002

Same author

The New Zealand Blood Donors' Health Study: baseline findings of a large prospective cohort study of injury.

Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention·2002

Same author

The official requirements for platelet concentrates.

Vox sanguinis·1999

Same author

A prospective cohort study of blood donors: methodological issues in the investigation of injuries and chronic diseases.

Australian and New Zealand journal of public health·1998

Same author

Antibody screening for recent Yersinia enterocolitica infection in blood donors.

Transfusion·1998

Same journal

Could we discuss the molecular signature of immune dysregulation?

Clinical and experimental immunology·2026

Same journal

The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

Clinical and experimental immunology·2026

Same journal

PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

Clinical and experimental immunology·2026

Same journal

Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

Clinical and experimental immunology·2026

Same journal

Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

Clinical and experimental immunology·2026

Same journal

Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

Clinical and experimental immunology·2026

See all related articles

Transfer factor did not alter the natural course of hepatitis B in a clinical trial. While early reductions in liver enzymes were observed, no significant differences were found between treatment and placebo groups.

Area of Science:

Hepatology
Immunology
Clinical Trials

Background:

Hepatitis B is a significant global health concern.
Exploring novel therapeutic agents for Hepatitis B is crucial.

Purpose of the Study:

To evaluate the efficacy of transfer factor in treating Hepatitis B.
To assess the impact of transfer factor on clinical and laboratory markers of Hepatitis B.

Main Methods:

Prospective, double-blind, placebo-controlled trial.
Twenty-nine patients with Hepatitis B were enrolled.
Participants received either transfer factor (n=13) or placebo (n=16).

Main Results:

No significant differences in clinical or laboratory measurements between groups.

Related Experiment Videos

A potential rapid early reduction in serum aspartate transaminase levels was noted with transfer factor.

No significant changes in in vitro lymphocyte function were observed.

Conclusions:

Transfer factor did not alter the natural course of Hepatitis B.
Further research may be needed to explore potential early effects on liver enzymes.